Interleukin-12
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='1F45' size='340' side='right' caption=' | + | <StructureSection load='1F45' size='340' side='right' caption='Glycosylated human interleukin-12 α chain (green) and β chain (grey) (PDB code [[1f45]]).' scene=''> |
== Background == | == Background == | ||
| - | Interleukin-12 also known as IL-12, is produced by many different cells such as macrophages, B cells, and neutrophils. These cells produce IL-12 to generate immunity to pathogens. It can also stimulate the proliferation of natural killer cells, which are cells that can specifically target and kill cells that have been affected by pathogens. IL-12 is also a heterodimeric glycoprotein. This means that IL-12 has two subunits that are linked by a di-sulfide bond. That di-sulfide bond is not necessary for the formation of IL-12. It is also not necessary for the secretion of IL-12, but the di-sulfide bonds help to stabilize the subunits. There have been studies done to see its effects on immunotherapy. | + | '''Interleukin-12''' also known as '''IL-12''', is produced by many different cells such as macrophages, B cells, and neutrophils. These cells produce IL-12 to generate immunity to pathogens. It can also stimulate the proliferation of natural killer cells, which are cells that can specifically target and kill cells that have been affected by pathogens. IL-12 is also a heterodimeric glycoprotein. This means that IL-12 has two subunits that are linked by a di-sulfide bond. That di-sulfide bond is not necessary for the formation of IL-12. It is also not necessary for the secretion of IL-12, but the di-sulfide bonds help to stabilize the subunits. There have been studies done to see its effects on immunotherapy. |
== What it is == | == What it is == | ||
| Line 18: | Line 18: | ||
Innate immunity is when the body has defense mechanisms that start working within hours of a pathogen being introduced into the body. Innate is the first line of defense against all pathogens, so there is no specificity pathogens; they attack anything. Adaptive immunity is acquired or specific. It is supposed to attack pathogens that are invading. If the immune system attacks the host organism, an autoimmune disorder develops. Adaptive immunity is done by B or T lymphoctyes. T helper cells secrete different cytokines like IL-12, which lets IL-12 activate innate natural killer cells and adaptive cytotoxic t cells.<ref name="immunotherapy">PMID:24514955</ref> IL-12 helps mature cytotoxic T cells so they can attack specific pathogens. <ref name="immunotherapy" /> It also helps stimulate the production of natural killer cells so they can start innate immunity. IL-12 is also produced by dendritic cells and monocytes. | Innate immunity is when the body has defense mechanisms that start working within hours of a pathogen being introduced into the body. Innate is the first line of defense against all pathogens, so there is no specificity pathogens; they attack anything. Adaptive immunity is acquired or specific. It is supposed to attack pathogens that are invading. If the immune system attacks the host organism, an autoimmune disorder develops. Adaptive immunity is done by B or T lymphoctyes. T helper cells secrete different cytokines like IL-12, which lets IL-12 activate innate natural killer cells and adaptive cytotoxic t cells.<ref name="immunotherapy">PMID:24514955</ref> IL-12 helps mature cytotoxic T cells so they can attack specific pathogens. <ref name="immunotherapy" /> It also helps stimulate the production of natural killer cells so they can start innate immunity. IL-12 is also produced by dendritic cells and monocytes. | ||
| - | To increase the production of IL-12 it can be done through priming or amplification. <ref name="immunotherapy" /> In priming, | + | To increase the production of IL-12 it can be done through priming or amplification. <ref name="immunotherapy" /> In priming, IL-12 would bind to the receptors on a ligand allowing it to move through the immune system faster. Amplification happens through a cytokine network where different cytokines get secreted through different cells. |
IL-12 has many actions. One action is stimulating the growth and cytotoxicity of natural killer cells. They also convert th0 cells into th1 cells by activating specific transcription factors. <ref name="immunotherapy" /> IL-12 also stimulates the production of <scene name='84/843022/Interferon/1'>interferon gamma</scene> which is another type of cytokine used in innate and adaptive immunity. <ref name="immunotherapy" /> Interferon gamma is secreted by T cells and natural killer cells; also it promotes macrophage activation, meaning it helps more macrophages to be activated so it can phagocytose bacteria, viruses, and fungi. <ref name="interferon">PMID:10688427</ref> IL-12 also helped to introduce IgG and suppress IgE from B cells. IgG is the most common antibody released from plasma B cells and has two antigen binding sites. IgE is an antibody that is produced when the immune system reacts to an allergen. All those actions that IL-12 performs help it with its anti-tumor effects. In animal studies, IL-12 has been useful in tumor therapy. <ref name="immunotherapy" /> Its effectiveness increases when used with other therapeutic models. | IL-12 has many actions. One action is stimulating the growth and cytotoxicity of natural killer cells. They also convert th0 cells into th1 cells by activating specific transcription factors. <ref name="immunotherapy" /> IL-12 also stimulates the production of <scene name='84/843022/Interferon/1'>interferon gamma</scene> which is another type of cytokine used in innate and adaptive immunity. <ref name="immunotherapy" /> Interferon gamma is secreted by T cells and natural killer cells; also it promotes macrophage activation, meaning it helps more macrophages to be activated so it can phagocytose bacteria, viruses, and fungi. <ref name="interferon">PMID:10688427</ref> IL-12 also helped to introduce IgG and suppress IgE from B cells. IgG is the most common antibody released from plasma B cells and has two antigen binding sites. IgE is an antibody that is produced when the immune system reacts to an allergen. All those actions that IL-12 performs help it with its anti-tumor effects. In animal studies, IL-12 has been useful in tumor therapy. <ref name="immunotherapy" /> Its effectiveness increases when used with other therapeutic models. | ||
Current revision
| |||||||||||
